Document:

EXHIBIT 4.1

                                CERTIFICATION
I, Richard Salvador, Chief Executive Officer certify that:

1.              I have reviewed this quarterly report on Form 10-QSB of
Angiogenex, Inc. (the "Registrant");

2.              Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of circumstances under which
such statements were made, not misleading with respect to the period covered
by this report;

3.              Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
Registrant as of, and for, the periods presented in this report.

4.              The Registrant's other certifying officers and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
for the Registrant and have:

       a)      Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
Registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared;

       b)     Evaluated the effectiveness of the Registrant's disclosure
controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and

       c)      Disclosed in this report any change in the Registrant's
internal control over financial reporting that occurred during the
Registrant's most recent fiscal quarter (the Registrant's fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the Registrant's
internal control over financial reporting; and

5.              The Registrant's other certifying officers and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the Registrant's auditors and the audit
committee of the Registrant's board of directors (or persons performing
the equivalent functions):

       (a)    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the Registrant's
ability to record, process, summarize and report financial
information; and

       (b)    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the Registrant's internal
control over financial reporting.

Date: August 14, 2006              By: /s/ Richard Salvador
                                -------------------------------
                                        Richard Salvador
                                        Chief Executive Officer

<PAGE>EXHIBIT 4.2

                                CERTIFICATION

I, Martin Murray, Chief Financial Officer certify that:

1.              I have reviewed this quarterly report on Form 10-QSB of
AngioGenex, Inc. (the "Registrant");

2.              Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of circumstances under which
such statements were made, not misleading with respect to the period covered
by this report;

3.              Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
Registrant as of, and for, the periods presented in this report.

4.              The Registrant's other certifying officers and I are
responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
for the Registrant and have:

       a)      Designed such disclosure controls and procedures, or caused
such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the
Registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared;

       b)     Evaluated the effectiveness of the Registrant's disclosure
controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and

       c)      Disclosed in this report any change in the Registrant's
internal control over financial reporting that occurred during the
Registrant's most recent fiscal quarter (the Registrant's fourth
fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the
Registrant's internal control over financial reporting; and

5.              The Registrant's other certifying officers and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to the Registrant's auditors and the audit
committee of the Registrant's board of directors (or persons performing
the equivalent functions):

       (a)    All significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the Registrant's
ability to record, process, summarize and report financial
information; and

       (b)    Any fraud, whether or not material, that involves management or
other employees who have a significant role in the Registrant's internal
control over financial reporting.

Date: August 14, 2006                   By: /s/ Martin Murray
                                     ------------------------------
                                             Martin Murray
                                             Chief Financial Officer

<PAGE>EXHIBIT 4.3

                          CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of AngioGenex, Inc. ("the Company")
on Form 10-QSB for the quarter ended June 30, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, Richard Salvador, Chief Executive Officer of the Company and
Martin Murray, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to our knowledge:

   (1)The Report fully complies with the requirements of Section 13(a) or
15(d)of the Securities Exchange Act of 1934; and

   (2)The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Dated: August 14, 2006

/s/ Richard Salvador                      /s/ Martin Murray
- --------------------                      -------------------
    Richard Salvador                          Martin Murray,
    Chief Executive Officer                   Chief Financial Officer

<PAGE>Exhibit 10.1(b)

             Schedule of Secured Convertible Note (demand) Issued by
              NCT Group, Inc. to Carole Salkind on August 16, 2006

    Issue Date       Due Date           Principal         Conversion Price
    ----------       --------           ---------         ----------------
     08/16/06        Earlier of:        $550,000       Greater of:  (i) $0.0022;
                     (i) demand;                       or (ii) the par value of
                     or (ii) 02/16/07                  NCT Group, Inc.
                                                       common stock on the
                                                       date of conversionExhibit 10.1

                            MDU Resources Group, Inc.
                             2006 Base Compensation

<TABLE>
<CAPTION>
                                                     Current Base            New Base
        Name                     Title             Compensation ($)      Compensation ($)
        ----                     -----             ----------------      ----------------
<S>                   <C>                       <C>                    <C>
 Terry D. Hildestad          President and              525,000              625,000*
                        Chief Executive Officer

</TABLE>

-----------------------
*Effective August 18, 2006

                                        6Exhibit 10.1
                                                                    ------------

                                 PROMISSORY NOTE

                                                           Salt Lake City, Utah
$5,797.00                                                    Date: July 7, 2006

For  cash  advanced   during  the  years  calendar  years  2002  and  2003,  the
undersigned,  LILM, INC., (hereinafter "Maker"), promises to pay to the order of
ALEWINE LIMITED LIABILITY COMPANY, at 1390 South 1100 East, Suite 204, Salt Lake
City, UT, 84111 (hereinafter  "Payee"), the principal sum of Five Thousand Seven
Hundred Ninety-Seven Dollars ($5,797.00) in lawful money of the United States of
America.

Payment of principal shall be due upon demand by the holder hereof.

The Maker of this Promissory  Note shall have the privilege,  without penalty or
premium, of paying in advance the entire principal or any portion thereof.

In the event  that any  portion  of  principal  is not paid  when due,  it shall
thereafter  bear  interest  at the rate of ten percent  (10.0%) per annum,  both
before and after  judgment,  until paid in full.  In the event of default on any
payment herein  provided for, then without  notice,  presentment or demand,  the
principal sum hereof  together with any accrued  interest  thereon shall, at the
option  of  the  holder  of  this  Promissory  Note,   become  due  and  payable
immediately.  Failure to delay in exercising  its option shall not  constitute a
waiver of any such  breach  or  default  nor  waiver  of the  holder's  right to
exercise said option upon any subsequent breach or default.

The undersigned hereby expressly waives all statutes of limitation affecting the
enforceability  of  this  Promissory  Note,  and  agree  to pay  all  reasonable
attorneys  fees and costs  incurred in  collection  of  payments  due, or in the
enforcement of any right or remedy hereunder. The Makers,  assumers,  endorsers,
sureties,  and  guarantors  of this  Promissory  Note  consent to all  renewals,
indulgences,  extensions,  and all releases of security  granted or permitted by
the owner or holder without notice.

Payment of this promissory note is unsecured.

                                        MAKER:

                                        LILM, INC.

                                        By:   /s/ George I. Norman III
                                              ------------------------
                                        Its:  President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]